OtherCardiovascular
Potent in vivo anti-angiogenic effects of GS-101, an antisense oligonucleotide preventing the expression of Insulin Receptor Substrate-1
Salman Al-Mahmood, Sylvie Colin, Nada Farhat, Eric Thorin, Cecile Steverlynck and Sylvain Chemtob
Journal of Pharmacology and Experimental Therapeutics February 10, 2009, DOI: https://doi.org/10.1124/jpet.108.147496
Salman Al-Mahmood
Sylvie Colin
Nada Farhat
Eric Thorin
Cecile Steverlynck
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherCardiovascular
Potent in vivo anti-angiogenic effects of GS-101, an antisense oligonucleotide preventing the expression of Insulin Receptor Substrate-1
Salman Al-Mahmood, Sylvie Colin, Nada Farhat, Eric Thorin, Cecile Steverlynck and Sylvain Chemtob
Journal of Pharmacology and Experimental Therapeutics February 10, 2009, DOI: https://doi.org/10.1124/jpet.108.147496
OtherCardiovascular
Potent in vivo anti-angiogenic effects of GS-101, an antisense oligonucleotide preventing the expression of Insulin Receptor Substrate-1
Salman Al-Mahmood, Sylvie Colin, Nada Farhat, Eric Thorin, Cecile Steverlynck and Sylvain Chemtob
Journal of Pharmacology and Experimental Therapeutics February 10, 2009, DOI: https://doi.org/10.1124/jpet.108.147496
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement